Cycle length is typically 4 to 8 weeks, with a clinical review at the midpoint to assess response
You might see injectable GHK-Cu offered by online gray-market retailers selling supplies from unregulated pharmaciesbut this is a big red flag and safety risk
Below, well break down how cagrilintide works, what clinical trials show so far, how it compares with existing options like Wegovy and Zepbound, and what the road ahead may look like for approval and availability
Do They Work the Same Way
Its confidence interval spans zero and is wider than the point estimate, so it was too small to detect the difference it observed uninformative rather than null
The side effects we see in clinic are generally mild: transient injection site reaction, occasional mild nausea if starting at too high a dose, infrequent headache or lightheadedness in the first week